US drug company to pay $1.6bn over improper marketing of Depakote®
Source: BBC Health Area: News According to a news report published by BBC Health, Abbott Laboratories has agreed to pay out $1.6bn (£1bn) after improperly marketing Depakote® (valproic acid).#160; The sales team were apparently encouraged to market the drug for uses that were outside of its licensed indications, including dementia and autism.#160; The court papers also said that the company marketed Depakote® to treat schizophrenia, despite clinical trials failing to demonstrate that it was any more effective than antipsychotic drugs in treating the condition. #160; Abbott Laboratories will now pay $800m to federal and state governments, $700m in criminal penalties and a further $100m to resolve consumer protection issues.#160; The company has additionally agreed to a five-yea...

IUDs, Implants Best for Long-Term Birth Control: Study
Unplanned pregnancy rate 20 times higher for birth control pill, patch or ring (Source: The Doctors Lounge - Health News)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div